Programmed Death-1 Polymorphisms is Associated with Risk of Esophagogastric Junction Adenocarcinoma in the Chinese Han Population: A Case-Control Study Involving 2,740 Subjects

Weifeng Tang,Shuchen Chen,Yu Chen,Jihong Lin,Jiangbo Lin,Yafeng Wang,Chao Liu,Mingqiang Kang

DOI: https://doi.org/10.18632/oncotarget.17338

2017-01-01

Oncotarget

Abstract:Single nucleotide polymorphisms (SNPs) inProgrammed cell death 1 (PD-1) gene may contribute to the development of cancer.In this study, we selected PD-1 rs10204525 T>C, rs2227982 A>G, rs36084323 T>C and rs7421861 A>G polymorphisms and designed a hospital-based case-control study to determine the potential relationship between these functional SNPs in PD-1 gene and esophagogastric junction adenocarcinoma (EGJA) risk.A total of 1,063 EGJA patients and 1,677 controls were enrolled from Eastern Chinese Han population.SNPscan TM genotyping assay was used to analyze the genotyping of PD-1 polymorphisms.We found that PD-1 rs7421861 A>G polymorphism was associated with the development of EGJA.However, PD-1 rs2227982 A>G polymorphism was a protective factor for EGJA.In addition, PD-1 rs36084323 CC homozygote genotype might be associated with a borderline decreased risk of EGJA.In a subgroup analysis, a decreased risk of EGJA in never drinking and never smoking groups was identified.Haplotype comparison analysis suggested that PD-1 T rs10204525 G rs2227982 C 36084323 A rs7421861 haplotype significantly decreased the risk of EGJA.However, T rs10204525 G rs2227982 C 36084323 G rs7421861 haplotype in PD-1 gene may confer risk to EGJA.In conclusion, our study highlights rs2227982 A>G, rs36084323 T>C and rs7421861 A>G polymorphisms and haplotypes in PD-1 gene, especially within the intron region, are significantly associated with the risk of EGJA.Further case-control studies with larger sample size and detailed geneenvironmental data to replicate these findings in different populations are needed to validate our conclusion.